Ithaca, NY, United States of America

Joyce M VanEck



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Joyce M VanEck

Introduction

Joyce M VanEck is a prominent inventor based in Ithaca, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of immunoprotective compositions derived from transgenic plants. With a total of 2 patents, her work has the potential to impact vaccine preparations and agricultural biotechnology.

Latest Patents

Joyce M VanEck's latest patents focus on vectors and cells for preparing immunoprotective compositions derived from transgenic plants. These inventions are directed towards vectors and methods that facilitate the preparation of genetically transformed plant cells. These cells express immunogens from pathogenic organisms, which are utilized to produce immunoprotective particles beneficial in vaccine formulations. The inventions include plant-optimized genes that encode the HN protein of Newcastle Disease Virus. Additionally, they relate to methods of producing an antigen in a transgenic plant.

Career Highlights

Throughout her career, Joyce has worked with notable organizations such as Dow Agrosciences LLC and the Boyce Thompson Institute for Plant Research. Her expertise in plant biotechnology has allowed her to contribute to advancements in the field, particularly in the area of vaccine development.

Collaborations

Joyce M VanEck has collaborated with esteemed colleagues, including Guy A Cardineau and Hugh S Mason. These partnerships have further enriched her research and innovations in biotechnology.

Conclusion

Joyce M VanEck's contributions to the field of biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in immunoprotective compositions and vaccine development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…